• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非阀门式青光眼引流装置植入术后难治性低眼压的经内路管结扎术

Ab interno tube ligation for refractory hypotony following non-valved glaucoma drainage device implantation.

作者信息

Vergados A, Mohite A A, Sung Velota C T

机构信息

Birmingham and Midland Eye Centre, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Dudley Road, Birmingham, B18 7QH, UK.

Whipps Cross University Hospital, Whipps Cross Road, London, E11 1NR, UK.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2271-2278. doi: 10.1007/s00417-019-04400-4. Epub 2019 Jul 22.

DOI:10.1007/s00417-019-04400-4
PMID:31332510
Abstract

PURPOSE

To report the 2-year outcomes of a novel surgical technique allowing reduction of the intraluminal diameter of the tube without total tube occlusion in order to allow enough increase in outflow resistance to permit resolution of hypotony whilst also achieving adequate IOP control.

METHODS

This was a single-surgeon retrospective case note review of all non-valved GDD cases over an 8-year period (2008-2015) that underwent ab interno ligation of the drainage tube in order to manage post-operative hypotony (Baerveldt or Molteno). Twelve eyes of 12 patients (4.4%) developing refractory hypotony that did not respond to multiple intracameral ophthalmic viscoelastic device (OVD) injections were included in this retrospective case series and were treated with our ab interno tube ligation technique. The post-ligation management algorithm consisted of re-instating topical anti-glaucoma agents, laser suture lysis (LSL), or further ab interno ligation.

RESULTS

Mean IOP increased from 2.8 mmHg at baseline to 7.8 mmHg, 7.1 mmHg, 9.0 mmHg, 13.6 mmHg, 10.9 mmHg, 13.9 mmHg and 13.6 mmHg at day 1, week 1, month 1, month 3, month 6, year 1 and year 2 respectively, with or without additional topical anti-glaucoma medications. Although hypotony resolution following our technique was achieved in all eyes at 2 years, 8.3% of cases required reinstatement of topical medications to maintain IOP control within the target range.

CONCLUSIONS

We propose ab interno partial tube tying as an effective surgical option to achieve an immediate, predictable and sustained IOP elevation either as a primary procedure or when traditional methods have failed to resolve hypotony in eyes with non-valved GDDs.

摘要

目的

报告一种新型手术技术的2年随访结果,该技术可在不完全闭塞引流管的情况下减小管腔内直径,从而充分增加房水流出阻力,以促进低眼压的缓解,同时实现眼压的充分控制。

方法

这是一项由单名外科医生进行的回顾性病例记录研究,纳入了8年期间(2008 - 2015年)所有接受经内路引流管结扎术以治疗术后低眼压的无阀门青光眼引流装置(GDD)病例(Baerveldt或Molteno)。本回顾性病例系列纳入了12例患者的12只眼(4.4%),这些患者出现难治性低眼压,对多次前房内注射眼科粘弹性剂(OVD)均无反应,并接受了我们的经内路引流管结扎技术治疗。结扎术后的管理方案包括重新使用局部抗青光眼药物、激光缝线松解术(LSL)或进一步的经内路结扎术。

结果

平均眼压从基线时的2.8 mmHg分别在术后第1天、第1周、第1个月、第3个月、第6个月、第1年和第2年升高至7.8 mmHg、7.1 mmHg、9.0 mmHg、13.6 mmHg、10.9 mmHg、13.9 mmHg和13.6 mmHg,无论是否使用额外的局部抗青光眼药物。尽管2年后所有患眼均通过我们的技术实现了低眼压缓解,但8.3%的病例需要重新使用局部药物以将眼压维持在目标范围内。

结论

我们建议经内路部分引流管结扎术作为一种有效的手术选择,无论是作为初始手术,还是在传统方法未能解决无阀门GDD患者的低眼压问题时,都能实现眼压的即刻、可预测和持续升高。

相似文献

1
Ab interno tube ligation for refractory hypotony following non-valved glaucoma drainage device implantation.非阀门式青光眼引流装置植入术后难治性低眼压的经内路管结扎术
Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2271-2278. doi: 10.1007/s00417-019-04400-4. Epub 2019 Jul 22.
2
Outcome of fixed volume intracameral sodium hyaluronate 1.4% injection for early postoperative hypotony after Baerveldt glaucoma implant.贝伐单抗青光眼植入术后早期低眼压行固定容量房水玻璃酸钠 1.4% 注射的疗效。
Clin Exp Ophthalmol. 2018 Dec;46(9):1035-1040. doi: 10.1111/ceo.13347. Epub 2018 Jul 10.
3
Ab Interno Tube Occlusion for Postoperative Hypotony in a Patient With an Ahmed Glaucoma Drainage Device.眼内管阻塞治疗 Ahmed 青光眼引流装置术后低眼压
J Glaucoma. 2018 Mar;27(3):e61-e63. doi: 10.1097/IJG.0000000000000869.
4
Systematic Occlusion of Shunts: Control of Early Postoperative IOP and Hypotony-related Complications Following Glaucoma Shunt Surgery.分流管的系统性闭塞:青光眼分流术后早期眼压控制及低眼压相关并发症的防治
J Glaucoma. 2016 Jan;25(1):54-61. doi: 10.1097/IJG.0000000000000135.
5
Intraluminal Suture Placement for Management of Hypotony After Glaucoma Drainage Device Surgery.青光眼引流装置手术后低眼压的管腔内缝线放置处理。
J Glaucoma. 2024 Aug 1;33(8):607-611. doi: 10.1097/IJG.0000000000002381. Epub 2024 Mar 28.
6
Truncation of In Situ Baerveldt Glaucoma Drainage Device for Treatment of Late Persistent Postoperative Hypotony.原位Baerveldt青光眼引流装置截短术治疗晚期持续性术后低眼压
J Glaucoma. 2017 Feb;26(2):e113-e114. doi: 10.1097/IJG.0000000000000601.
7
Downsizing a Baerveldt Glaucoma Implant For the Management of Persistent Postoperative Hypotony: A Case Series.贝伐单抗青光眼植入物缩小术治疗持续性术后低眼压:病例系列研究。
J Glaucoma. 2019 Nov;28(11):1019-1022. doi: 10.1097/IJG.0000000000001365.
8
EyeWatch Rescue of Refractory Hypotony After Baerveldt Drainage Device Implantation: Description of a New Technique.眼内液引流装置植入后难治性低眼压的 EyeWatch 挽救:一种新技术的描述。
J Glaucoma. 2020 Feb;29(2):e7-e10. doi: 10.1097/IJG.0000000000001417.
9
Surgical management of hypotony owing to overfiltration in eyes receiving glaucoma drainage devices.接受青光眼引流装置的眼睛因滤过过度导致低眼压的手术治疗
J Glaucoma. 2009 Oct-Nov;18(8):638-41. doi: 10.1097/IJG.0b013e31819aa4e0.
10
XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes.XEN 增强型 Baerveldt 引流装置植入治疗难治性青光眼:1 年结果。
Graefes Arch Clin Exp Ophthalmol. 2020 Aug;258(8):1787-1794. doi: 10.1007/s00417-020-04654-3. Epub 2020 May 6.

引用本文的文献

1
Recent Advancements in Glaucoma Surgery-A Review.青光眼手术的最新进展——综述
Bioengineering (Basel). 2023 Sep 19;10(9):1096. doi: 10.3390/bioengineering10091096.
2
Commentary: Countering the hype related to hypotony in nonvalved Aurolab aqueous drainage implant.评论:应对与非瓣膜式Aurolab房水引流植入物低眼压相关的炒作。
Indian J Ophthalmol. 2023 Feb;71(2):593-594. doi: 10.4103/ijo.IJO_2284_22.
3
Commentary: Meeting the nemesis of a non-valved glaucoma drainage device head-on.评论:直面无阀青光眼引流装置的克星。

本文引用的文献

1
Management of Postoperative Ocular Hypotony after Tube Surgery by Stenting Using Two 5-0 Nylon Threads.使用两根5-0尼龙线支架治疗引流管手术后的术后低眼压
Korean J Ophthalmol. 2018 Dec;32(6):523-524. doi: 10.3341/kjo.2018.0092.
2
Xen Gel Stent to Resolve Late Hypotony After Glaucoma Drainage Implant Surgery: A Novel Technique.Xen 凝胶支架治疗青光眼引流植入术后晚期低眼压:一种新方法。
J Glaucoma. 2018 Oct;27(10):926-928. doi: 10.1097/IJG.0000000000001022.
3
Outcome of fixed volume intracameral sodium hyaluronate 1.4% injection for early postoperative hypotony after Baerveldt glaucoma implant.
Indian J Ophthalmol. 2022 Jun;70(6):2182-2183. doi: 10.4103/ijo.IJO_1057_22.
4
Insertion of a Preserflo microshunt inside a non-valved glaucoma shunt to treat late-onset hypotony.在无阀青光眼引流管内插入 Preserflo 微分流管治疗迟发性低眼压。
Indian J Ophthalmol. 2022 Jun;70(6):2180-2182. doi: 10.4103/ijo.IJO_22_22.
5
Corneal Edema and Keratoplasty: Risk Factors in Eyes With Previous Glaucoma Drainage Devices.角膜水肿和角膜移植术:既往青光眼引流装置眼的危险因素。
Am J Ophthalmol. 2022 Jun;238:27-35. doi: 10.1016/j.ajo.2021.12.017. Epub 2022 Jan 5.
6
Analytical model for managing hypotony after implantation surgery of a glaucoma drainage device.青光眼引流装置植入术后低眼压管理的分析模型。
Biomech Model Mechanobiol. 2021 Dec;20(6):2061-2070. doi: 10.1007/s10237-021-01494-w. Epub 2021 Jul 23.
7
Commentary: Intraluminal stenting of non-flow restrictive glaucoma drainage devices.评论:非流量限制性青光眼引流装置的管腔内支架置入术
Indian J Ophthalmol. 2020 Jun;68(6):1153-1154. doi: 10.4103/ijo.IJO_30_20.
贝伐单抗青光眼植入术后早期低眼压行固定容量房水玻璃酸钠 1.4% 注射的疗效。
Clin Exp Ophthalmol. 2018 Dec;46(9):1035-1040. doi: 10.1111/ceo.13347. Epub 2018 Jul 10.
4
Glaucoma drainage device surgery in children and adults: a comparative study of outcomes and complications.儿童和成人青光眼引流装置手术:结局与并发症的比较研究
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):1003-1011. doi: 10.1007/s00417-017-3584-2. Epub 2017 Feb 1.
5
The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes.艾哈迈德对 Baerveldt 研究:五年治疗结果。
Ophthalmology. 2016 Oct;123(10):2093-102. doi: 10.1016/j.ophtha.2016.06.035. Epub 2016 Aug 17.
6
Corneal endothelial cell loss after Baerveldt glaucoma drainage device implantation in the anterior chamber.前房植入Baerveldt青光眼引流装置后的角膜内皮细胞丢失
Acta Ophthalmol. 2017 Feb;95(1):91-96. doi: 10.1111/aos.13161. Epub 2016 Aug 6.
7
Secondary stenting of glaucoma drainage implant: a novel technique for treatment of late hypotony.青光眼引流植入物的二次支架置入:一种治疗晚期低眼压的新技术。
Clin Exp Ophthalmol. 2016 Dec;44(9):860-861. doi: 10.1111/ceo.12784. Epub 2016 Jun 30.
8
A novel use of reticulated hyaluronic acid (Healaflow) for hypotony eyes in patients with uveitis.网状透明质酸(Healaflow)在葡萄膜炎患者低眼压眼中的新用途。
Br J Ophthalmol. 2016 Jun;100(6):727-30. doi: 10.1136/bjophthalmol-2015-307799. Epub 2016 Mar 25.
9
Five-year treatment outcomes in the Ahmed Baerveldt comparison study.艾哈迈德·贝尔费尔特比较研究中的五年治疗结果。
Ophthalmology. 2015 Feb;122(2):308-16. doi: 10.1016/j.ophtha.2014.08.043. Epub 2014 Oct 17.
10
Systematic Occlusion of Shunts: Control of Early Postoperative IOP and Hypotony-related Complications Following Glaucoma Shunt Surgery.分流管的系统性闭塞:青光眼分流术后早期眼压控制及低眼压相关并发症的防治
J Glaucoma. 2016 Jan;25(1):54-61. doi: 10.1097/IJG.0000000000000135.